DeepMed Research

Rogel Cancer Center: University of Michigan

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1991-01-01

Employees: -

Market Cap: -

Website: http://www.rogelcancercenter.org

Clinical Trials

Living Well With Lymphoma

Not Applicable

Recruiting

Conditions: Lymphoma

Interventions: Other: Fatigue Reduction Diet
Other: General Health Curriculum

First Posted Date: 2023-09-21

Last Posted Date: 2024-12-13

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 68

Registration Number: NCT06047626

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

Feasibility of Expressive Writing for Body Image Distress and Anxiety Among Adolescent and Young Adult Cancer Survivors

Not Applicable

Active, not recruiting

Conditions: Young Adult Cancer
Body Image
Adolescent Cancer

Interventions: Other: BI Focused writing
Other: Control

First Posted Date: 2023-09-21

Last Posted Date: 2025-05-18

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 30

Registration Number: NCT06046014

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, Node Positive, HR+/HER2- Breast Cancer

Phase 1

Recruiting

Conditions: Breast Cancer

Interventions: Drug: Ribociclib
Radiation: Postoperative Radiation Therapy

First Posted Date: 2023-08-16

Last Posted Date: 2025-02-19

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 30

Registration Number: NCT05996107

Locations: 🇺🇸
UHCMC Seidman Cancer Center, Cleveland, Ohio, United States
🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸
University of Michigan Health West, Wyoming, Michigan, United States

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

Phase 2

Recruiting

Conditions: Pancreatic Adenocarcinoma
Adenosquamous Carcinoma
Pancreatic Neuroendocrine Tumor
Pancreatic Neuroendocrine Carcinoma
Gastrointestinal Neuroendocrine Tumor
Gastrointestinal Neuroendocrine Carcinoma
Neuroendocrine Prostate Carcinoma

Interventions: Drug: ESK981

First Posted Date: 2023-08-14

Last Posted Date: 2025-02-26

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 66

Registration Number: NCT05988918

Locations: 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸
Rogel Cancer Center, Ann Arbor, Michigan, United States
🇺🇸
University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States

Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe

Recruiting

Conditions: Prostate Cancer

Interventions: Device: Fine Needle Photoacoustic Probe

First Posted Date: 2023-07-28

Last Posted Date: 2024-10-31

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 20

Registration Number: NCT05965180

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas

Phase 2

Recruiting

Conditions: Cutaneous T Cell Lymphoma
Fungoides Mycosis Sezary Syndrome

Interventions: Drug: Pembrolizumab
Drug: Mogamulizumab

First Posted Date: 2023-07-21

Last Posted Date: 2025-04-08

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 23

Registration Number: NCT05956041

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation

Not Applicable

Recruiting

Conditions: Hematopoietic Stem Cell Transplant

Interventions: Other: Cardio-oncology program

First Posted Date: 2023-07-14

Last Posted Date: 2025-05-02

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 10

Registration Number: NCT05945121

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

Trial of Devimistat in Combination With Modified FOLFIRINOX in Patients With Metastatic Adenocarcinoma of the Pancreas

Phase 1

Withdrawn

Conditions: Metastatic Pancreatic Adenocarcinoma

Interventions: Drug: Devimistat
Drug: Modified FOLFIRINOX

First Posted Date: 2023-07-03

Last Posted Date: 2023-08-02

Lead Sponsor: University of Michigan Rogel Cancer Center

Registration Number: NCT05926206

Locations: 🇺🇸
Rogel Cancer Center, Ann Arbor, Michigan, United States

Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors

Not Applicable

Recruiting

Conditions: Anxiety

Interventions: Other: TiMBRe
Other: Control

First Posted Date: 2023-06-20

Last Posted Date: 2025-04-10

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 50

Registration Number: NCT05911269

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

Phase 2

Recruiting

Conditions: Hepatocellular Carcinoma

Interventions: Drug: Prednisone

First Posted Date: 2023-06-13

Last Posted Date: 2025-03-12

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 20

Registration Number: NCT05901519

Locations: 🇺🇸
Rogel Comprehensive Cancer Center, Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy